Sireesh Appajosyula
Directeur des opérations chez THARIMMUNE, INC.
Fortune : 15 991 $ au 31/05/2024
Postes actifs de Sireesh Appajosyula
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| THARIMMUNE, INC. | Directeur/Membre du Conseil | 01/07/2021 | - |
| Directeur des opérations | 10/07/2023 | - | |
| Independent Dir/Board Member | 01/07/2021 | - | |
| Highpoint Pharmaceuticals LLC | Corporate Officer/Principal | 01/01/2018 | - |
| Channel Bioconsulting LLC | Corporate Officer/Principal | 01/01/2015 | - |
Historique de carrière de Sireesh Appajosyula
Anciens postes connus de Sireesh Appajosyula
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| 9 METERS BIOPHARMA, INC. | Directeur des opérations | - | 17/07/2023 |
Salix Pharmaceuticals, Inc.
 Salix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Salix Pharmaceuticals Ltd., Salix Pharmaceuticals, Inc. is a company that manufactures pharmaceutical products. The company is based in Sunnyvale, CA. | Corporate Officer/Principal | - | - |
Formation de Sireesh Appajosyula
| Ernest Mario School of Pharmacy | Doctorate Degree |
| Rutgers State University of New Jersey | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 8 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Chief Operating Officer | 2 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| 9 METERS BIOPHARMA, INC. | Health Technology |
| THARIMMUNE, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| Highpoint Pharmaceuticals LLC | |
| Channel Bioconsulting LLC | |
Salix Pharmaceuticals, Inc.
Salix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Salix Pharmaceuticals Ltd., Salix Pharmaceuticals, Inc. is a company that manufactures pharmaceutical products. The company is based in Sunnyvale, CA. | Health Technology |
- Bourse
- Insiders
- Sireesh Appajosyula
- Expérience
